48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 13, Issue 11, Pages 1573
Publisher
MDPI AG
Online
2023-11-03
DOI
10.3390/jpm13111573
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
- (2023) Flavius-Alexandru Gherasie et al. Journal of Personalized Medicine
- Biodegradable-Polymer or Durable-Polymer Stents in Patients at High Bleeding Risk: A Randomized, Open-Label Clinical Trial
- (2023) Marco Valgimigli et al. CIRCULATION
- 2023 ESC Guidelines for the management of acute coronary syndromes
- (2023) Robert A Byrne et al. EUROPEAN HEART JOURNAL
- Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results
- (2023) Maciej Tyczyński et al. Journal of Clinical Medicine
- Preferable vascular healing of ultrathin strut biodegradable-polymer sirolimus-eluting stents in patients with acute coronary syndrome
- (2022) Akito Kawamura et al. Cardiovascular Intervention and Therapeutics
- Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials
- (2022) Rayyan Hemetsberger et al. Clinical Research in Cardiology
- Surgical Turned-Downed CHIP Cases—Can PCI Save the Day?
- (2022) Alexandru Achim et al. Frontiers in Cardiovascular Medicine
- Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study
- (2022) Yutaka Matsuhiro et al. Cardiovascular Intervention and Therapeutics
- Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review
- (2022) Attilio Leone et al. Journal of Personalized Medicine
- Differential impact of abluminal groove‐filled biodegradable‐polymer sirolimus‐eluting stent versus durable‐polymer everolimus‐eluting stent on and off dual antiplatelet therapy
- (2021) Yuichi Saito et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Comparison of a Bioresorbable, Magnesium-Based Sirolimus-Eluting Stent with a Permanent, Everolimus-Eluting Metallic Stent for Treating Patients with Acute Coronary Syndrome: the PRAGUE-22 Study
- (2021) Petr Toušek et al. CARDIOVASCULAR DRUGS AND THERAPY
- Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial
- (2021) Juan F. Iglesias et al. Cardiovascular Revascularization Medicine
- Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)
- (2020) Mario Iannaccone et al. BMC Cardiovascular Disorders
- Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest
- (2020) Mohamed A. Omer et al. JACC-Cardiovascular Interventions
- 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2020) Jean-Philippe Collet et al. EUROPEAN HEART JOURNAL
- Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?
- (2019) Mateusz P. Jeżewski et al. Journal of Clinical Medicine
- Coronary Stents: History, Design, and Construction
- (2018) Torrey Schmidt et al. Journal of Clinical Medicine
- Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients
- (2018) Ariel Roguin et al. Circulation-Cardiovascular Interventions
- Fourth universal definition of myocardial infarction (2018)
- (2018) Kristian Thygesen et al. EUROPEAN HEART JOURNAL
- Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial
- (2017) Hui-liang Liu et al. Journal of Cardiology
- Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model
- (2016) Piotr P. Buszman et al. Cardiology Journal
- Novel sirolimus-eluting stent Prolim® with a biodegradable polymer in the all-comers population: one year clinical results with quantitative coronary angiography and optical coherence tomography analysis
- (2015) Jacek Bil et al. BMC Cardiovascular Disorders
- Early Neointimal Coverage and Vasodilator Response Following Biodegradable Polymer Sirolimus-Eluting vs. Durable Polymer Zotarolimus-Eluting Stents in Patients With Acute Coronary Syndrome
- (2015) Pasi P. Karjalainen et al. CIRCULATION JOURNAL
- A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction
- (2015) Takumi Higuma et al. JACC-Cardiovascular Interventions
- Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents
- (2013) Tomohisa Tada et al. JACC-Cardiovascular Interventions
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
- (2013) Vasim Farooq et al. LANCET
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
- (2011) Kumaran Kolandaivelu et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now